3-cyanocoumarin has been researched along with coumarin 6 in 1 studies
| Studies (3-cyanocoumarin) | Trials (3-cyanocoumarin) | Recent Studies (post-2010) (3-cyanocoumarin) | Studies (coumarin 6) | Trials (coumarin 6) | Recent Studies (post-2010) (coumarin 6) |
|---|---|---|---|---|---|
| 7 | 0 | 4 | 172 | 0 | 149 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gonzalez-Velasquez, FJ; Moss, MA; Murphy, BP; Soto-Ortega, DD; Wang, Q; Wilson, KA; Xie, F | 1 |
1 other study(ies) available for 3-cyanocoumarin and coumarin 6
| Article | Year |
|---|---|
Inhibition of amyloid-β aggregation by coumarin analogs can be manipulated by functionalization of the aromatic center.
Topics: Amyloid beta-Peptides; Coumarins; Drug Design; Humans; Protein Binding; Protein Multimerization; Structure-Activity Relationship | 2011 |